Immunology Research and Perspectives (IRP) is an international, peer-reviewed, open-access journal dedicated to advancing research into the fundamental theory, disease mechanisms, and translational applications of the immune system. Published quarterly online by  GOSP, the journal aims to integrate fundamental immunology discoveries with clinical and therapeutic approaches to address global health challenges.

Open Access Policy‌:
All articles in Immunology Research and Perspectives are freely accessible under a full Open Access model. To encourage global knowledge exchange, the journal currently imposes ‌no Article Processing Charges (0 APC)‌ for authors.

‌Rapid Publication Timeline‌:

  • ‌Peer Review Efficiency‌: Manuscripts undergo rigorous peer review, with initial decisions provided to authors within ‌21 days‌ of submission.
  • ‌Acceptance to Publication‌: Accepted papers are published online within ‌14 days‌ of final acceptance, ensuring timely dissemination of critical engineering advancements.

‌Reviewer Recognition Program‌:
Reviewers who deliver timely, thorough, and constructive evaluations receive ‌APC Discount Vouchers‌ as acknowledgment of their contributions. These vouchers may be applied to reduce fees for future submissions in any journal within the GOSP network, fostering a collaborative scholarly community.

Scope and Vision:
IRP focuses on cutting-edge research in immune regulation, host-pathogen interactions, immunotherapy, and precision immunology. Key areas of focus include:

  • Molecular and cellular immune mechanisms in health and disease
  • Autoimmunity, inflammation, and immune tolerance networks
  • Vaccinology and emerging infectious disease defense strategies
  • Cancer immunology and novel immunotherapies (e.g., checkpoint inhibitors, CAR-T therapy)
  • Systems immunology, omics technologies, and computational modeling of immune responses

The journal serves as a platform for interdisciplinary collaboration, connecting immunologists, clinicians, and biotechnologists to address global challenges in epidemic preparedness, autoimmune diseases, cancer treatment, and vaccine development.